Faulty genes that raise meningitis risk identified
August 9th, 2010 - 1:34 pm ICT by ANILondon, Aug 9 (ANI): A new study of has revealed that genetic differences make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune.
The research, led by Imperial College London and the Genome Institute of Singapore, is the largest ever-genetic study of meningitis and septicaemia caused by meningococcal bacteria.
It suggests that people who develop these diseases have innate differences in their natural defences that leave them unable to attack meningococcal bacteria successfully.
The researchers hope that their new findings will boost the development of effective vaccines to combat the group B strain of the bacteria, for which there is currently no vaccine.
The study compared the genetic makeup of 1,500 people who developed meningococcal meningitis, from the UK, Holland, Austria and Spain, with over 5,000 healthy controls from the Wellcome Trust Case Control Consortium.
Researchers looked at half a million common genetic variants scattered across each person’s genome, and searched for differences between the patients with meningococcal disease and healthy controls.
The results revealed that those who had developed meningococcal meningitis had genetic markers in a number of genes involved in attacking and killing invading bacteria.
Professor Michael Levin of Imperial College (ICL) London said: “Although most of us have carried the meningitis bacteria at some point, only around one in 40,000 people develop meningococcal meningitis.
“Our study set out to understand what causes this small group of people to become very ill whilst others remain immune. Our findings provide the strongest evidence so far that there are genetic factors that lead to people developing meningitis.”
The variations uncovered in the study were around the genes for Factor H and Factor H-related proteins. These proteins regulate a part of the body’s immune system called the complement system, which recognises and kills invading bacteria.
Normally, Factor H and Factor H-related proteins ensure that the complement system does not cause excessive damage to the body’s own cells. However, meningococcal bacteria can hijack the body’s Factor H and use it to ensure that the body does not recognise the bacteria as foreign. The bacteria effectively use Factor H as a ‘Trojan Horse,’ enabling them to evade the body’s defences and preventing the immune system from killing them.
The findings were published in Nature Genetics. (ANI)
- Gene breakthrough leads to hope of meningitis vaccine soon - Aug 09, 2010
- Genetic clues to major cause of kidney disease worldwide found - Apr 06, 2011
- Meningitis bacteria dress up as human cells to evade body''s defences - Feb 19, 2009
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- New approach to study potentially deadly disease-causing bacteria - Dec 24, 2010
- New affordable vaccine offers hope in fight against meningitis - Nov 10, 2010
- TB shot found promising in animal tests - Sep 05, 2011
- New cell type boosts immunity to infection - Nov 30, 2011
- Vaccine to tackle meningitis 'just a year away' - Dec 24, 2010
- Meningitis bacteria mimic human cells to trick immune system - Feb 20, 2009
- Scientists close to finding meningococcal B shot - May 08, 2012
- New breakthrough paves way for vaccines against pneumonia, meningitis - Nov 12, 2010
- Gut bugs have vital bearing on health, immunity - Oct 11, 2011
- Secret of bacteria's immune system unlocked - Nov 05, 2010
- 'Immune evasion' uncommon in M. tuberculosis - May 24, 2010
Tags: case control, complement system, faulty genes, genetic differences, genetic factors, genetic makeup, genetic markers, genetic study, genetic variants, genome institute of singapore, half a million, imperial college london, meningococcal bacteria, meningococcal meningitis, michael levin, natural defences, professor michael, septicaemia, vaccines, wellcome trust case control consortium